Skip to main content
ONCOSIL MEDICAL LTD logo

ONCOSIL MEDICAL LTD — Investor Relations & Filings

Ticker · OSL ISIN · AU000000OSL3 ASX Manufacturing
Open in API
Filings indexed 1,201 across all filing types
Latest filing 2026-03-18 Major Shareholding Noti…
Country AU Australia
Listing ASX OSL

About ONCOSIL MEDICAL LTD

https://www.oncosil.com

OncoSil Medical Ltd is a medical technology company focused on the development and commercialization of localized treatments for patients with unresectable cancers. The company's lead product, OncoSil, is a targeted radioactive isotope microparticle therapy designed to deliver a concentrated dose of beta radiation directly into solid tumors. It is primarily indicated for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy. The device utilizes Phosphorus-32 microparticles administered via endoscopic ultrasound-guided fine-needle injection, providing a localized brachytherapy approach intended to reduce tumor volume and improve surgical resectability. OncoSil Medical holds regulatory approvals in multiple jurisdictions, including the CE Mark for use in the European Union and the United Kingdom, and continues to evaluate clinical applications for other solid tumor types.

Recent filings

Filing Released Lang Actions
Change in substantial holding from PCG 3 pages 324.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in Oncosil Medical Ltd, including dates and nature of changes, and lists associated entities and addresses. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2026-03-18 English
Becoming a substantial holder 3 pages 159.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001, titled 'Notice of initial substantial holder.' It details the substantial shareholding of Regal Partners Funds Management Pty Ltd and its associates in Oncosil Medical, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding crossing a threshold, which aligns with the category 'Major Shareholding Notification (MRQ).' There is no indication that this is a financial report, management announcement, or other types of filings. The document length and content confirm it is a substantive notification rather than a brief announcement or certification.
2026-03-18 English
Security Class Reinstatement to Quotation - OSLOE 1
Regulatory Filings Classification · 100% confidence The document is a brief market announcement from ASX Compliance regarding the reinstatement of a security class to quotation. It is short (586 characters) and does not contain financial data, detailed reports, or management commentary. It is an official regulatory announcement about listing status, fitting the category of Regulatory Filings (RNS) as it does not fit other specific categories like Annual Report or Capital Update.
2026-03-17 English
Results of Entitlement Offer 2 pages 293.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 March 2026 providing detailed results of a non-renounceable entitlement offer by OncoSil Medical Limited. It includes specifics on the number of new shares and options issued, gross proceeds raised, and allocation details including underwriter involvement. The document focuses on fundraising activities and capital raising, referencing the issue price, number of shares, and options, as well as the use of proceeds. There is no financial statement or comprehensive financial report content, nor is it a brief summary or presentation. It is not a report publication announcement since it contains substantive information about the capital raising event itself. Therefore, the document fits the category of Capital/Financing Update (CAP).
2026-03-16 English
Application for quotation of securities - OSL 7 pages 21.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form titled 'Application for quotation of securities' from Oncosil Medical Ltd. It details the application to list new securities on the ASX, including the number and type of securities, issue dates, and distribution schedules. This type of document is a formal announcement related to the quotation of securities on the stock exchange, which corresponds to announcements about new share issues or capital changes. It is not a financial report, earnings release, or management discussion. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is a full announcement, not a brief notice or a report publication announcement.
2026-03-16 English
Application for quotation of securities - OSL 6 pages 18.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Oncosil Medical Ltd regarding the application for quotation of securities on the ASX. It details the securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. This type of document is a formal application to list or quote securities on a stock exchange, which corresponds to announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital structure changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not merely a brief notice but a full application form, supporting high confidence.
2026-03-16 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.